Home Organizations Technologies Needs Capabilities Startups Success stories People
Login Sign Up
thumb

Louisiana State University Health Sciences Center New Orleans

2members, 0followers

SummaryCapabilitiesNeedsTechnology OfferingStartupsSuccess Stories
thumb

2,4,6-trimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid esters as Neuroprotective Drugs

The market for neuroprotective compounds is ever growing, in part due to an increasing incidence of traumatic brain injury (TBI) and neurodegenerative disorders (e.g., Alzheimer’s disease). ...
thumb

5-lipoxygenase inhibitors: (2-azinylamino) quinone derivatives

Forecasts predict that the global inflammatory therapeutics market will continue to grow at a CAGR of 5.8% between 2010 and 2017, to record sales of $85.9 billion. 5-lipoxygenase (5-LO) is a target ...
thumb

A Device for Cutting and Holding a Cornea During a Transplant Procedure

A device and surgical method for promoting suitable grafting between a healthy donor cornea button and a recipient's healthy corneal tissue.
thumb

A medicinal cocktail that reduces unwanted side effects characteristic of medical marijuana medical treatment

Currently, the medical marijuana market in the U.S. is worth $1.7 billion, a figure expected to rise as the legalization of medical marijuana spreads. Cannabis has been used for thousands of years ...
thumb

A Novel Tandem Reporter That Quantifies RNA Polymerase II Termination in Mammalian Cells

Researchers at LSU Health Sciences Center in New Orleans have discovered a novel reporter tandem reporter construct that is capable of assaying transcription termination when integrated into a ...
thumb

Angiogenic agents from plant extracts, gallic acid, and derivatives

The process of angiogenesis, the proliferation and development of new blood vessels, occurs in multiple pathological processes. Highlighting the potential economic importance of anti-angiogenic ...
thumb

Automated Hybridization System, Ideally suited for High-Throughput Western Blots

thumb

Distraction Osteogenesis Fixture

The market for dental tissue engineering devices is rapidly growing, expecting to reach $50 million by 2015. Researchers at LSUHSC in New Orleans have designed an improved distraction osteogenesis ...
thumb

Efficient High-Throughput Screen for Identifying Novel Anti-Fungal Compounds

High-throughput screening method for identifying novel compounds which target endolysosome/vacuole.
thumb

Etching Alumina Ceramics

This invention involves a thermochemical process that readily produces significantly roughened surfaces on densely sintered alumina. The resulting roughened alumina components have numerous uses in ...
thumb

Fluoride-releasing Compositions

Dental caries is a worldwide pandemic problem characterized by progressive demineralization and destruction of the hard tissues of the tooth. Fluoride is the most widely used agent to prevent dental ...
thumb

Genomic Yeast One Hybrid System

This assay provides a method of identifying specific gene targets of transcription factors by testing their ability to directly bind genomic elements in vivo.
thumb

High-strength corrosion-resistant aluminum alloy

Researchers at the LSU Health Sciences Center and the University of New Orleans have developed a novel adhesive composition comprising aluminum lithium alloy particles and a multifunctional polymer ...
thumb

Human Glucocorticoid Receptor 1A Promoter and Splice Variants

Researchers at the LSU Health Sciences Center have developed a method to detect the presence of cancerous lymphocytes and a method to determine the responsiveness of a patient with cancerous ...
thumb

Improved Nasogastric Tube

Nasogastric intubation is a medical process involving the insertion of a nasogastric tube through the nose, past the throat, and into the stomach. Problems associated with current tubes include ...
thumb

Inhibiting furin with polybasic peptides

Furin has been implicated in the activation of certain bacterial infections, as well as
in the metastatic progression of certain tumors. Inhibitors of furin have been reported; however their ...
thumb

Inhibition of angiogenesis and destruction of angiogenic vessels by apolipoprotein A-I and high density lipoprotein

Anti-angiogenesis therapeutics may be of use in treating disorders whose pathogenic mechanism includes abnormal or excessive vasculature. Excessive blood vessel proliferation in cancer-related ...
thumb

Inhibition of angiogenesis and destruction of angiogenic vessels with extracts of Noni juice

The process of angiogenesis, the proliferation and development of new blood vessels, occurs in multiple pathological processes. Researchers at LSU Health Sciences Center in New Orleans have ...
thumb

Injection of a Radioactive Dye for Sentinel Lymph Node Identification

A researcher at the LSU Health Sciences Center in New Orleans has developed a new intraoperative injection approach utilizing a novel, radiolabeled methylene blue dye for sentinel lymph node ...
thumb

Intracorneal Astigmatic Onlay

An intracorneal astigmatic, rectangular onlay has been discovered that can correct for astigmatism by physically adjusting the shape of the cornea.

Activity

May

14

Kevin Dietz created technology Process of fabricating nanofibers by reactive electrospinning

May

10

Kevin Dietz created technology Protein Structural Biomarkers to Guide Targeted Therapies

May

09

Kevin Dietz edited technology Therapeutic and Diagnostic Method for Ataxia Telangiectasia

May

08

Kevin Dietz created technology Automated Hybridization System, Ideally suited for High-Throughput Western Blots

May

01

Kevin Dietz created technology Therapeutic to restore cornea nerves after surgery

May

01

Kevin Dietz created technology White Blood Cell Differential Trainer

May

01

Kevin Dietz created technology Novel research tool to enhance homologous recombination efficiency

May

01

Kevin Dietz edited technology Method and Apparatus for Arterial and Venous Cannulation

Apr

23

Kevin Dietz created technology Synergistic combinations including N-acylated 4-Hydroxyphenylamine derivatives and caffeine

Apr

19

Kevin Dietz created technology 5-lipoxygenase inhibitors: (2-azinylamino) quinone derivatives

Message

Members

Tag Cloud

biotechnology cancer Devices Diagnostics Disease: Cancer imaging materials medical medical devices Other Research Tools software Software therapeutic Therapeutics More...